A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/02/1999	WO1999061047A1 Compound delivery using rapidly dissolving collagen film
12/02/1999	WO1999061045A1 Topical drug for the treatment of viral infections
12/02/1999	WO1999061044A1 Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption
12/02/1999	WO1999061043A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999	WO1999061042A1 Compositions and methods for enhancing protein anabolism and detoxification
12/02/1999	WO1999061041A1 Novel peptides
12/02/1999	WO1999061040A2 USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE
12/02/1999	WO1999061039A2 Novel composition for modulating ischemic cell death
12/02/1999	WO1999061001A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
12/02/1999	WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999	WO1999060984A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/02/1999	WO1999055564A8 Materials and methods for gene therapy
12/02/1999	WO1999053958A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
12/02/1999	WO1999053942A8 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
12/02/1999	WO1999053091A9 Dna coding for gdnf, parts of said dna and gdnf variants
12/02/1999	WO1999052548A3 Conjugate vaccines for the prevention of dental caries
12/02/1999	WO1999052523A3 Flutamide compositions and preparations
12/02/1999	WO1999050425A3 Regulated apoptosis using chemically induced dimerization of apoptosis factors
12/02/1999	WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999	WO1999048518A3 Medicament for preventing or treating papilloma virus-specific tumors
12/02/1999	WO1999047173A3 Carrier for in vivo delivery of a therapeutic agent
12/02/1999	WO1999046381A9 Human fgf gene and gene expression products
12/02/1999	WO1999045938B1 Thrombin preparation and products and fibrin sealant methods employing same
12/02/1999	WO1999044636A3 Il-12 enhancement of immune responses to t-independent antigens
12/02/1999	WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999	WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
12/02/1999	WO1999035262A3 Apoptosis inducing molecule ii
12/02/1999	WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999	WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999	DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
12/02/1999	DE19823831A1 Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen New pharmaceutical use of isoleucyl thiazolidide and its salts
12/02/1999	DE19823319A1 Topisch anwendbares Arzneimittel zur Behandlung von Virusinfektionen Topical application medicines for the treatment of viral infections
12/02/1999	CA2343317A1 Novel peptides
12/02/1999	CA2334940A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999	CA2333667A1 Murd protein and gene of pseudomonas aeruginosa
12/02/1999	CA2333592A1 Methods of inhibiting clot formation
12/02/1999	CA2333167A1 Method for purification of borrelia lipoprotein ospa
12/02/1999	CA2333159A1 Method
12/02/1999	CA2333006A1 Calmodulin related protein
12/02/1999	CA2332979A1 Correlative protection using ospa antibody titers
12/02/1999	CA2332772A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	CA2330611A1 Bifunctional molecules and therapies based thereon
12/02/1999	CA2329274A1 Interleukin-21
12/02/1999	CA2329269A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999	CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999	CA2329157A1 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins
12/02/1999	CA2329155A1 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
12/02/1999	CA2329143A1 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999	CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999	CA2329072A1 Human transmembrane proteins
12/02/1999	CA2329053A1 Human socs proteins
12/02/1999	CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999	CA2328905A1 Prostate growth-associated membrane proteins
12/02/1999	CA2328892A1 Tumor suppressor
12/02/1999	CA2328604A1 Compositions and methods of modulating an immune response to an antigen
12/02/1999	CA2328524A1 Human cd45+ and/or fibroblast + mesenchymal stem cells
12/02/1999	CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999	CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein
12/02/1999	CA2327541A1 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/01/1999	EP0960941A1 Gene Therapy for cell proliferative diseases
12/01/1999	EP0960937A1 Novel semaphorin gene: semaphorin y
12/01/1999	EP0960936A1 Reconstituted human anti-hm1.24 antibody
12/01/1999	EP0960935A1 Novel mouse cxc chemokine receptor
12/01/1999	EP0960888A1 Novel semaphorin genes (i)
12/01/1999	EP0960887A1 T cell epitope peptide
12/01/1999	EP0960886A1 Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
12/01/1999	EP0960885A1 Depsipeptides and drugs containing the same as the active ingredient
12/01/1999	EP0960622A2 Use of pharmaceutical compositions containing both IL-6 and IL-12 for the activation of T cells
12/01/1999	EP0960572A1 Nutritional composition for the treatment of pressure ulcers
12/01/1999	EP0960335A2 Modulators of insulin receptor activity
12/01/1999	EP0960334A1 Vegf-b/receptor complex and uses thereof
12/01/1999	EP0960216A1 Treatment of hiv infection by interfering with host topoisomerase interaction with hiv gag and rt
12/01/1999	EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999	EP0960202A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor
12/01/1999	EP0960196A1 Novel receptor that causes cell death
12/01/1999	EP0960193A1 ISOLATION AND CLONING OF THE HUMAN hARSA-I GENE AND USES THEREOF
12/01/1999	EP0960192A1 Synthetic polynucleotides
12/01/1999	EP0960191A1 Compositions and methods for use of defensin
12/01/1999	EP0960183A2 Photochemical singlet oxygen generators having enhanced singlet oxygen yields
12/01/1999	EP0960130A1 Oxygen-binding heme proteins incorporating circularly-permuted globins
12/01/1999	EP0960129A1 MELATONIN 1a RECEPTOR GENE REGULATORY REGIONS AND USES THEREOF
12/01/1999	EP0960128A1 Gene product over expressed in cancer cells
12/01/1999	EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
12/01/1999	EP0960124A1 Serine substituted mutants of bcl-xl/bcl-2 associated cell death regulator
12/01/1999	EP0960123A1 Sprouty protein and coding sequence
12/01/1999	EP0960122A1 Myelopeptides and their therapeutic use
12/01/1999	EP0960120A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
12/01/1999	EP0960119A1 T cell antigen receptor peptides
12/01/1999	EP0960118A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
12/01/1999	EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999	EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
12/01/1999	EP0959904A2 Hybrid compositions for intracellular targeting
12/01/1999	EP0959903A1 NOVEL FabD
12/01/1999	EP0959899A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
12/01/1999	EP0959898A1 Lactoferrin variants and uses thereof
12/01/1999	EP0959897A1 Method of regulating nitric oxide production
12/01/1999	EP0959896A2 Human thyrotropin receptor compositions and use thereof
12/01/1999	EP0959895A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
12/01/1999	EP0959874A1 High dose liposomal aerosol formulations
12/01/1999	EP0959873A2 Gel composition and methods

1 ... 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 ... 3163